|
News for Healthier Living
Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer
A new study has identified a set of plasma proteins that can predict whether patients with triple-negative breast cancer (TNBC) will respond to immunotherapy. By analyzing blood samples from 195 TNBC patients, researchers discovered that proteins like ARG1, NOS3 and CD28 are strongly linked to treatment outcomes.
August 15, 2025
August 15 2025August 14 2025August 13 2025August 12 2025August 11 2025August 10 2025August 9 2025August 8 2025August 7 2025August 6 2025August 5 2025August 4 2025August 3 2025August 2 2025
|
|
|
|
|